Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...
The "Bowel Management Systems - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The bowel management systems market was valued at ...
Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...
27.5% from Medtronic, 22.5% from Nevro, 11.8% from Abbott, and 1.3% from Saluda. Among 47 patients implanted with Abbott devices, 34% received a system for DRG stimulation. The ean (SD ...
With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved ...
In this group, 37% of patients received devices from Boston Scientific, 27.5% from Medtronic, 22.5% from Nevro, 11.8% from Abbott, and 1.3% from Saluda. Among 47 patients implanted with Abbott devices ...
Medtronic in Santa Ana says its layoffs would be temporary while it repairs the roof of its medical device-making facility, while Avante Health Solutions in San Clemente hopes to retain its staff ...
Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback